BECN1 and BIM interactions with MCL-1 determine fludarabine resistance in leukemic B cells

被引:33
|
作者
Sharma, A. [1 ,2 ]
Singh, K. [1 ]
Mazumder, S. [1 ]
Hill, B. T. [3 ]
Kalaycio, M. [3 ]
Almasan, A. [1 ]
机构
[1] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA
[2] Cleveland State Univ, Cleveland, OH 44115 USA
[3] Cleveland Clin, Taussig Canc Inst, Dept Hematol Oncol & Blood Disorders, Cleveland, OH 44106 USA
来源
CELL DEATH & DISEASE | 2013年 / 4卷
基金
美国国家卫生研究院;
关键词
autophagy; MCL-1; BECN1; BIM; fludarabine resistance; CHRONIC LYMPHOCYTIC-LEUKEMIA; CYTOCHROME-C RELEASE; CASPASE ACTIVATION; UP-REGULATION; AUTOPHAGY; BCL-2; EXPRESSION; PHOSPHORYLATION; APOPTOSIS; DEATH;
D O I
10.1038/cddis.2013.155
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The purine analog fludarabine (Fd) is an essential therapeutic for chronic lymphocytic leukemia (CLL). Innate or acquired resistance to Fd is a significant clinical problem and is largely mediated by increased expression of BCL-2 family members. The antiapoptotic BCL-2 family proteins inhibit both apoptosis and autophagy, therefore, downregulation of antiapoptotic BCL-2 family proteins and enhanced autophagy must coexist in cells dying in response to an apoptosis inducing therapeutic. However, in the drug-resistant cells that have an increased dependence on antiapoptotic proteins, whether autophagy is also inhibited remains unclear. Here, we examined the role of the BCL-2 family in regulating cell death and autophagy in leukemic cell lines and their derivative isogenic Fd-resistant (FdR) cells. MCL-1 degradation following Fd treatment freed the proapoptotic effectors BIM and BECN1, thus leading to cell death-associated autophagy in Fd-sensitive cells. However, in FdR cells, low BIM expression and BECN1 sequestration by MCL-1 prevented cell death. Consistently, in sensitive cells inhibition of apoptosis using siBIM and of both the early-phase autophagy nucleation steps by siBECN1, shATG7 or 3-methyladenine and the late-phase autophagy by shLAMP2, significantly reduced Fd-induced cell death. Paradoxically, FdR cells were addicted to basal autophagy, which was dependent on AMP-activated protein kinase (AMPK) but not BECN1. Moreover, in FdR cells, inhibition of autophagy by shLAMP2, but not siBECN1, enhanced cell death. The BH3-mimetic obatoclax released BIM and BECN1 from MCL-1 in Fd-sensitive and BECN1 from MCL-1 in FdR cells, and was effective at killing both Fd-sensitive and - resistant leukemic cells, including primary CLL cells. Therefore, a differential regulation of autophagy through BECN1 and AMPK signaling in Fd-sensitive and - resistant cells determines the different possible outcomes of autophagy inhibition. These findings suggest effective means to overcome Fd resistance by induction of BIM-dependent apoptosis and activation of BECN1-dependent autophagy.
引用
收藏
页码:e628 / e628
页数:10
相关论文
共 50 条
  • [31] miR-193b Modulates Resistance to Doxorubicin in Human Breast Cancer Cells by Downregulating MCL-1
    Long, Jingpei
    Ji, Zhiwei
    Jiang, Kai
    Wang, Zhaoyang
    Meng, Guanmin
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [32] Divaricoside Exerts Antitumor Effects, in Part, by Modulating Mcl-1 in Human Oral Squamous Cell Carcinoma Cells
    Weng, Jing-Ru
    Bai, Li-Yuan
    Chiu, Shih-Jiuan
    Chiu, Chang-Fang
    Lin, Wei-Yu
    Hu, Jing-Lan
    Shieh, Tzong-Ming
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2019, 17 : 151 - 159
  • [33] AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance
    Balakrishnan, Kumudha
    Burger, Jan A.
    Wierda, William G.
    Gandhi, Varsha
    BLOOD, 2009, 113 (01) : 149 - 153
  • [34] Inhibition of cyclin E1 overcomes temozolomide resistance in glioblastoma by Mcl-1 degradation
    Liang, Huaxin
    Chen, Zhuo
    Sun, Libo
    MOLECULAR CARCINOGENESIS, 2019, 58 (08) : 1502 - 1511
  • [35] Osteosarcoma cells depend on MCL-1 for survival, and osteosarcoma metastases respond to MCL-1 antagonism plus regorafenib in vivo
    Ji, Yanhao
    Harris, Michael A.
    Newton, Lucas M.
    Harris, Tiffany J.
    Fairlie, W. Douglas
    Lee, Erinna F.
    Hawkins, Christine J.
    BMC CANCER, 2024, 24 (01)
  • [36] MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complex
    Konopleva, M.
    Milella, M.
    Ruvolo, P.
    Watts, J. C.
    Ricciardi, M. R.
    Korchin, B.
    McQueen, T.
    Bornmann, W.
    Tsao, T.
    Bergamo, P.
    Mak, D. H.
    Chen, W.
    McCubrey, J.
    Tafuri, A.
    Andreeff, M.
    LEUKEMIA, 2012, 26 (04) : 778 - 787
  • [37] Fludarabine induces apoptosis in chronic lymphocytic leukemia - the role of P53, Bcl-2, Bax, Mcl-1, and Bag-1 proteins
    Faria, JR
    Yamamoto, M
    Faria, RMD
    Kerbauy, J
    Oliveira, JSR
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2006, 39 (03) : 327 - 333
  • [38] Mcl-1 inhibition overcomes intrinsic and acquired regorafenib resistance in colorectal cancer
    Song, Xiangping
    Shen, Lin
    Tong, Jingshan
    Kuang, Chaoyuan
    Zeng, Shan
    Schoen, Robert E.
    Yu, Jian
    Pei, Haiping
    Zhang, Lin
    THERANOSTICS, 2020, 10 (18): : 8098 - 8110
  • [39] Mcl-1 Is Up Regulated by Prenylated Coumarin, Umbelliprenin in Jurkat Cells
    Gholami, Omid
    Jeddi-Tehrani, Mahmood
    Iranshahi, Mehrdad
    Zarnani, Amir Hassan
    Ziai, Seyed Ali
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2014, 13 (04): : 1387 - 1392
  • [40] IL-15 regulates Bcl-2 family members Bim and Mcl-1 through JAK/STAT and PI3K/AKT pathways in T cells
    Shenoy, Aparna R.
    Kirschnek, Susanne
    Haecker, Georg
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2014, 44 (08) : 2500 - 2507